# Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control

> **NCT02571608** · PHASE4 · WITHDRAWN · sponsor: **McMaster University**

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02571608
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study halted prematurely, prior to enrollment of first participant
- **Last updated:** 2021-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02571608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02571608, "Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02571608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*